Cargando…
ADCY7 mRNA Is a Novel Biomarker in HPV Infection and Cervical High-Grade Squamous Lesions or Higher
The effect of cervical cancer immunotherapy is limited. Combination therapy will be a new direction for cervical cancer. Thus, it is essential to discover a novel and available predictive biomarker to stratify patients who may benefit from immunotherapy for cervical cancer. In this study, 563 partic...
Autores principales: | Chen, Lihua, Huang, Lixiang, Dong, Binhua, Gu, Yu, Cang, Wei, Li, Chen, Sun, Pengming, Xiang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045083/ https://www.ncbi.nlm.nih.gov/pubmed/36979847 http://dx.doi.org/10.3390/biomedicines11030868 |
Ejemplares similares
-
HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
por: Chen, Lihua, et al.
Publicado: (2020) -
Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration
por: chen, Lihua, et al.
Publicado: (2022) -
Coinfection of High-Risk Human Papillomavirus and Lower Genital Tract Pathogens in the Development of High-Grade Cervical Lesions
por: Zhong, Hui, et al.
Publicado: (2020) -
Prognostic value of HPV 16/18 genotyping and geminin mRNA quantification in low-grade cervical squamous intraepithelial lesion
por: Zheng, Ziwen, et al.
Publicado: (2021) -
Prevalence of HPV and Assessing Type-Specific HPV Testing in Cervical High-Grade Squamous Intraepithelial Lesions in Poland
por: Przybylski, Marcin, et al.
Publicado: (2023)